Increased hepatocyte growth factor levels over 2 years are associated with coronary heart disease: the Multi-Ethnic Study of Atherosclerosis (MESA)

Paul A. Decker, Nicholas Larson, Elizabeth J. Bell, James S. Pankow, Naomi Q. Hanson, Christina L. Wassel, Michael Y. Tsai, Suzette J Bielinski

Research output: Contribution to journalLetter


Hepatocyte growth factor (HGF) is associated with subclinical and clinical atherosclerosis. However, the significance of change in HGF and development of atherosclerotic disease is unknown. In a large and diverse population-based cohort, we report that change in the biomarker HGF is an independent predictor of incident CHD.

Original languageEnglish (US)
Pages (from-to)30-34
Number of pages5
JournalAmerican Heart Journal
StatePublished - Jul 1 2019


ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this